C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/19/2002	WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002	WO2002100426A1 Bmp binding proteins for use in bone or cartilage regeneration
12/19/2002	WO2002100424A1 Antiviral composition incorporating lectins
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100343A2 N-terminally truncated galectin-3 and antibodies for treating cancer
12/19/2002	WO2002100340A2 Improved vaccination against anthrax
12/19/2002	WO2002100324A2 Compositions and methods for the repair and construction of bone and other tissue
12/19/2002	WO2002100317A2 Targeted particles and methods of using the same
12/19/2002	WO2002100250A2 Wit 3.0, a novel gene to control soft tissue wound healing
12/19/2002	WO2002100199A2 Modifying nicotine and nitrosamine levels in tobacco
12/19/2002	WO2002085937A3 Inflammation-specific peptides and the uses thereof
12/19/2002	WO2002082904A3 Method of treating or retarding the development of blindness
12/19/2002	WO2002082075A9 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
12/19/2002	WO2002079475A3 Streptococcus pyogenes antigens and corresponding dna fragments
12/19/2002	WO2002077157A9 Insect nuclear receptor genes and uses thereof
12/19/2002	WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
12/19/2002	WO2002074079A3 Polynucleotide encoding a gene conferring resistance to bacillus thuringiensis toxins
12/19/2002	WO2002072824A3 Human transient receptor potential channel protein.
12/19/2002	WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002068462A3 Internal standard for electrophoretic and chromatographic separation processes
12/19/2002	WO2002066682A3 Rat toxicologically relevant genes and uses thereof
12/19/2002	WO2002066603A3 Chemically defined medium for cultured mammalian cells
12/19/2002	WO2002066506A3 Use of casb7439 (ash2) in the immunotherapy of breast cancer
12/19/2002	WO2002064780A9 Dna sequences for human tumour suppressor genes
12/19/2002	WO2002064025A3 Inhibition of atf2 activity to treat cancer
12/19/2002	WO2002062370A9 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
12/19/2002	WO2002059257A3 Method and means for producing barley yellow dwarf virus resistant cereal plants
12/19/2002	WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders
12/19/2002	WO2002057787A3 Detection of survivin in the biological fluids of cancer patients
12/19/2002	WO2002057455A8 Nucleic acid sequences from drosophila melanogaster that encode proteins essential for larval viability and uses thereof
12/19/2002	WO2002055542A3 Hpv-specific peptides, which block the binding of hpv to the host cell
12/19/2002	WO2002050293A3 Plants with improved resistance
12/19/2002	WO2002050261A3 PROTEINS THAT INTERACT WITH βTRCP
12/19/2002	WO2002050104A9 Methods and cells for detecting modulators of rgs proteins
12/19/2002	WO2002048353A3 Dna-sequences, which code for an apoptosis signal transduction protein
12/19/2002	WO2002040512A3 Human beta-defensin-3
12/19/2002	WO2002033111A3 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
12/19/2002	WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002	WO2002022825A3 The c. albicans tec1 gene (catec1) and the coded tec1p protein
12/19/2002	WO2002022824A3 Ashbya gossypii genes coding for proteins involved in membrane transport
12/19/2002	WO2002012338A3 Screening method
12/19/2002	WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses
12/19/2002	WO2002004665A3 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
12/19/2002	WO2001092297A3 Regulation of human lgr4-like g protein-coupled receptor
12/19/2002	WO2001083739A3 Human pellino polypeptides
12/19/2002	WO2001082788A9 Compounds and methods for the treatment and prevention of bacterial infection
12/19/2002	WO2001079481A8 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
12/19/2002	WO2001077331A9 Human trp-like calcium channel protein-2 (tlcc-2)
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001073026A9 43238, a novel g protein-coupled receptor and uses therefor
12/19/2002	WO2001072994A9 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
12/19/2002	WO2001070931A9 A MAMMALIAN OOCYTE-SPECIFIC LINKER HISTONE GENE H1oo
12/19/2002	WO2001070245A9 Immune mediators and related methods
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	WO2001004335A3 Human-bovine chimeric respiratory syncytial virus vaccines
12/19/2002	US20020194648 Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
12/19/2002	US20020194646 Methods of creating dwarf phenotypes in plants
12/19/2002	US20020194645 Combinations of genes for producing seed plants exhibiting modulated reproductive development
12/19/2002	US20020194643 Method for producing hemin proteins using plant cells, resulting proteins and products containing same
12/19/2002	US20020194641 PUFA polyketide synthase systems and uses thereof
12/19/2002	US20020194640 Plant promoter derived from luminal binding protein gene and methods for its use
12/19/2002	US20020194639 Bonsai, a phospholipid binding protein, is required for thermal tolerance in arabidopsis
12/19/2002	US20020194636 Transgenic mice containing polycystin-related gene disruptions
12/19/2002	US20020194635 Transgenic bovine for use as animal model in the treatment of viral diseases
12/19/2002	US20020194634 Insect control system
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/19/2002	US20020194630 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
12/19/2002	US20020194628 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof
12/19/2002	US20020193585 Novel human transporter proteins and polynucleotides encoding the same
12/19/2002	US20020193584 Endogenous and non-endogenous versions of human G protein-coupled receptors
12/19/2002	US20020193582 69624, a novel human transporter family member and uses therefor
12/19/2002	US20020193580 Synthetic nucleotide sequences for use as tools in controlling genetic engineering
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193570 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/19/2002	US20020193569 Immunoconjugate for use in the treatment of cancer
12/19/2002	US20020193568 Protein for use as tools in controlling gene expression
12/19/2002	US20020193567 Secreted proteins and polynucleotides encoding them
12/19/2002	US20020193566 Protein library for use in classofocation of protein structure
12/19/2002	US20020193565 Antigen preparation and use
12/19/2002	US20020193564 Polypeptide for use in the treatment of muscular, huntington's and alzhemiers's diseases
12/19/2002	US20020193563 Randomly generated glycopeptide combinatorial libraries
12/19/2002	US20020193561 P53 protein variants and therapeutic uses thereof
12/19/2002	US20020193338 Applying a biocompatible matrix containing the DNA molecule to a wound in the body, so that repair cells that migrate to the wound site infiltrate the matrix, acquire the DNA molecule, and express the gene product encoded by the DNA in vivo
12/19/2002	US20020193332 Identifying a mammal that has or is at risk for having a bladder disorder; administering an isolated nucleic acid comprising an unmethylated CpG sequence to the mammal, to thereby modulate an immune response in the mammal
12/19/2002	US20020193330 Genetically engineered co-expression DNA vaccines, construction methods and uses thereof
12/19/2002	US20020193329 Useful as vaccines
12/19/2002	US20020193328 Use of gene product of adenovirus early region 4 ORF-6 to inhibit repair of double-strand breaks in DNA
12/19/2002	US20020193326 Methods of inhibiting proliferative diseases
12/19/2002	US20020193325 Inhibiting growth of a tumor cell by introducing to the cell an effective amount of p19ARF protein or mimetic thereof, and p53
12/19/2002	US20020193310 For therapy of hyperglycemic disorders
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193308 Recombinant protein and its use in therapy and diagnostics
12/19/2002	US20020193305 Cytokine receptor common gamma chain like
12/19/2002	US20020193302 Use of FVIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/19/2002	US20020193301 Administering transforming growth factor alpha (TGF- alpha ) polypeptide, fragments and mimetics fragments and mimetics for protection of a tissue or an organ from damage by a cytotoxic agent
12/19/2002	US20020193300 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020193299 For use as pharmaceuticals, diagnostics, biosensors and bioreactors

1 ... 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 ... 2916